Although human induced pluripotent stem cells (hiPSCs) have enormous potential in
regenerative medicine, their epigenetic variability suggests that some lines may not be …

Human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells (hESCs)
are promising candidate cell sources for regenerative medicine. However, despite the …

Human induced pluripotent stem cells (hiPSCs) show variable differentiation potential due to
their epigenomic heterogeneity, whose extent/attributes remain unclear, except for well …

Generation of human induced pluripotent stem cells (hiPSCs) by the expression of specific
transcription factors depends on successful epigenetic reprogramming to a pluripotent state …

The usefulness of human induced pluripotent stem cells (hiPSCs) in research and
therapeutic applications highly relies on their genomic integrity and stability. Many …

Many reprogramming methods can generate human induced pluripotent stem cells (hiPSCs)
that closely resemble human embryonic stem cells (hESCs). This has led to assessments of …

Much of the excitement generated by induced pluripotent stem cell technology is concerned
with the possibility of disease modeling as well as the potential for personalized cell therapy …

Pluripotent stem cells derived from both embryonic and reprogrammed somatic cells have
significant potential for human regenerative medicine. Despite similarities in developmental …

A library of well-characterized human induced pluripotent stem cell (hiPSC) lines from
clinically healthy human subjects could serve as a useful resource of normal controls for in …

The developmental potential of human pluripotent stem cells suggests that they can produce
disease-relevant cell types for biomedical research. However, substantial variation has been …